| Walmart Pharmacy 10/3511 | |
| 550 W Honeysuckle Ave, Hayden, Idaho 83835 | |
| (208) 209-4081 |
| Name | Walmart Pharmacy 10/3511 |
|---|---|
| Organization Name | Walmart Inc |
| Location | 550 W Honeysuckle Ave, Hayden, Idaho 83835 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (208) 209-4081 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
BioNumerik Pharmaceuticals, Inc. today announced the treatment of the first patients in a global multi-center Phase III clinical trial of Tavocept (BNP7787) in patients with primary adenocarcinoma of the lung, the most common type of lung cancer. In previous studies, Tavocept demonstrated the potential to substantially increase overall and one year patient survival while concurrently preventing and reducing the incidence and severity of common chemotherapy side-effects as compared to other currently available treatments for advanced lung cancer.
A new observational study in Germany, recently published on the medRxiv* preprint server, found the Comirnaty vaccine to be 68.3% effective against COVID-19 for people over 80. In those fully immunized, the vaccine was found to be 73.2% effective in preventing hospitalization and 80.1% effective against death.
Apolipoprotein E (APOE), a gene associated with heightened risk for Alzheimer's disease in adults, can also increase the likelihood that brain-injured newborns will develop cerebral palsy, researchers at Children's Memorial Research Center have discovered.
New Jersey residents will have access to the newest clinical trials and medical breakthroughs as a result of an innovative consortium between Rutgers University, Princeton University and the New Jersey Institute of Technology.
At the Society for Neuroscience Annual Meeting, being held from November 13-17, PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the launch of a panel of epigenetics-based detection reagents to enable high-throughput screening (HTS) for new drug candidates. The new assay kits can screen for epigenetic factors to assist researching diseases such as neurodegeneration and cancer.
› Verified 9 days ago
| NPI Number | 1730493834 |
| Organization Name | WALMART INC. |
| Doing Business As | WALMART PHARMACY 10-3511 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 550 W Honeysuckle Ave, Hayden, ID 83835 |
| Phone Number | 208-209-4081 |
News Archive
BioNumerik Pharmaceuticals, Inc. today announced the treatment of the first patients in a global multi-center Phase III clinical trial of Tavocept (BNP7787) in patients with primary adenocarcinoma of the lung, the most common type of lung cancer. In previous studies, Tavocept demonstrated the potential to substantially increase overall and one year patient survival while concurrently preventing and reducing the incidence and severity of common chemotherapy side-effects as compared to other currently available treatments for advanced lung cancer.
A new observational study in Germany, recently published on the medRxiv* preprint server, found the Comirnaty vaccine to be 68.3% effective against COVID-19 for people over 80. In those fully immunized, the vaccine was found to be 73.2% effective in preventing hospitalization and 80.1% effective against death.
Apolipoprotein E (APOE), a gene associated with heightened risk for Alzheimer's disease in adults, can also increase the likelihood that brain-injured newborns will develop cerebral palsy, researchers at Children's Memorial Research Center have discovered.
New Jersey residents will have access to the newest clinical trials and medical breakthroughs as a result of an innovative consortium between Rutgers University, Princeton University and the New Jersey Institute of Technology.
At the Society for Neuroscience Annual Meeting, being held from November 13-17, PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the launch of a panel of epigenetics-based detection reagents to enable high-throughput screening (HTS) for new drug candidates. The new assay kits can screen for epigenetic factors to assist researching diseases such as neurodegeneration and cancer.
› Verified 9 days ago
News Archive
BioNumerik Pharmaceuticals, Inc. today announced the treatment of the first patients in a global multi-center Phase III clinical trial of Tavocept (BNP7787) in patients with primary adenocarcinoma of the lung, the most common type of lung cancer. In previous studies, Tavocept demonstrated the potential to substantially increase overall and one year patient survival while concurrently preventing and reducing the incidence and severity of common chemotherapy side-effects as compared to other currently available treatments for advanced lung cancer.
A new observational study in Germany, recently published on the medRxiv* preprint server, found the Comirnaty vaccine to be 68.3% effective against COVID-19 for people over 80. In those fully immunized, the vaccine was found to be 73.2% effective in preventing hospitalization and 80.1% effective against death.
Apolipoprotein E (APOE), a gene associated with heightened risk for Alzheimer's disease in adults, can also increase the likelihood that brain-injured newborns will develop cerebral palsy, researchers at Children's Memorial Research Center have discovered.
New Jersey residents will have access to the newest clinical trials and medical breakthroughs as a result of an innovative consortium between Rutgers University, Princeton University and the New Jersey Institute of Technology.
At the Society for Neuroscience Annual Meeting, being held from November 13-17, PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the launch of a panel of epigenetics-based detection reagents to enable high-throughput screening (HTS) for new drug candidates. The new assay kits can screen for epigenetic factors to assist researching diseases such as neurodegeneration and cancer.
› Verified 9 days ago
Rite Aid Pharmacy 06200 Type: Pharmacy Location: 43 West Prairie Shopping Cente, Hayden, Idaho 83835 Phone: (208) 772-2774 | |
Sav-on Pharmacy #254 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 161 W Prairie Ave, Hayden, Idaho 83835 Phone: (208) 772-7864 | |
Walmart Pharmacy 10/3511 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 550 W Honeysuckle Ave, Hayden, Idaho 83835 Phone: (208) 209-4081 | |
Medicine Man Prairie Pharmacy Type: Pharmacy Location: 8093 N Cornerstone Dr, Hayden, Idaho 83835 Phone: (208) 762-9355 | |
Walgreens #10314 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 260 W Honeysuckle Ave, Hayden, Idaho 83835 Phone: (208) 762-0185 |